AIRLINK 196.20 Increased By ▲ 2.64 (1.36%)
BOP 10.02 Increased By ▲ 0.07 (0.7%)
CNERGY 7.85 Decreased By ▼ -0.08 (-1.01%)
FCCL 39.90 Decreased By ▼ -0.75 (-1.85%)
FFL 17.09 Increased By ▲ 0.23 (1.36%)
FLYNG 27.15 Decreased By ▼ -0.60 (-2.16%)
HUBC 133.59 Increased By ▲ 1.01 (0.76%)
HUMNL 14.00 Increased By ▲ 0.11 (0.79%)
KEL 4.65 Increased By ▲ 0.05 (1.09%)
KOSM 6.66 Increased By ▲ 0.04 (0.6%)
MLCF 47.19 Decreased By ▼ -0.41 (-0.86%)
OGDC 215.31 Increased By ▲ 1.40 (0.65%)
PACE 6.95 Increased By ▲ 0.02 (0.29%)
PAEL 41.80 Increased By ▲ 0.56 (1.36%)
PIAHCLA 17.22 Increased By ▲ 0.07 (0.41%)
PIBTL 8.53 Increased By ▲ 0.12 (1.43%)
POWER 9.73 Increased By ▲ 0.09 (0.93%)
PPL 184.50 Increased By ▲ 2.15 (1.18%)
PRL 42.85 Increased By ▲ 0.89 (2.12%)
PTC 25.15 Increased By ▲ 0.25 (1%)
SEARL 112.80 Increased By ▲ 5.96 (5.58%)
SILK 1.01 Increased By ▲ 0.02 (2.02%)
SSGC 44.11 Increased By ▲ 4.01 (10%)
SYM 17.78 Increased By ▲ 0.31 (1.77%)
TELE 8.97 Increased By ▲ 0.13 (1.47%)
TPLP 13.00 Increased By ▲ 0.25 (1.96%)
TRG 67.39 Increased By ▲ 0.44 (0.66%)
WAVESAPP 11.65 Increased By ▲ 0.32 (2.82%)
WTL 1.82 Increased By ▲ 0.03 (1.68%)
YOUW 4.00 Decreased By ▼ -0.07 (-1.72%)
BR100 12,218 Increased By 173.1 (1.44%)
BR30 36,913 Increased By 333 (0.91%)
KSE100 115,432 Increased By 1394 (1.22%)
KSE30 36,318 Increased By 523.5 (1.46%)

With the reference to SRO 412/2014 by Drug Regulatory Authority; Aamir Iqbal, Senior Vice Chairman of the Federation of Pakistan Chamber of Commerce and Industry Committee on Health Care, humility appealed Prime Minister of Pakistan, Mian Mohammad Nawaz Sharif, Finance Minister Ishaq Dar, Minister National Health Services and application of regulatory and communicated to Ms Tarar Saira Afzal to intervene directly in the case about the ban on the sale of Skin care products, herbal, traditional, Chinese, and various food supplements, imported medicines.
He raised the issue that due to such steps may result in the ill-treatment of users and millions of patients may affect the trafficking, parallel trade import and ESP, spurious and fake products will be encouraged. According to international practice and international custom tariffs and import policy under the category of cosmetic products already have been classified.
Human resources and manpower, and the ability of pharmaceutical registration DRA Pharma importers paid a license fee, and they still have the board's agenda, nor do they consider Registration date for the ESP biological and Research Thousands of products, are pending applications are pending in drap. -PR

Copyright Business Recorder, 2015

Comments

Comments are closed.